Professor Dr. Gökhan Hotamışlıgil from Harvard University. Dr. Hotamisligil’s research focuses on the regulatory pathways, which control glucose and lipid metabolism. His interdisciplinary mechanistic and physiological studies centered around organelle function, inflammatory and stress signaling, and biology of novel lipids aim to identify new pathways that are involved in human metabolic and inflammatory diseases including obesity, diabetes, fatty liver disease, atherosclerosis, and asthma and develop strategies to target these paths for preventive and therapeutic applications. Dr. Hotamisligil’s work has been revolutionary in developing the concept that obesity promotes inflammation and is associated with a variety of other factors that contribute to insulin resistance, type 2 diabetes, and other chronic illnesses and led to the emergence of the field of immunometabolism. He also serves as an Associate Member of both the Broad Institute and the Harvard Stem Cell Institute. Dr. Hotamisligil received his MD degree from Ankara University and his PhD from Harvard University.
